Mary Katherine Ladone's Insider Trades & SAST Disclosures
Mary Katherine Ladone's most recent trade in Inogen Inc was a trade of 30,612 Common Stock done . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mary Katherine Ladone.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inogen Inc | Mary Katherine Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 30,612 | 76,885 (0%) | 0% | 0 | Common Stock | |
| Novanta Inc | Mary Katherine Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,325 | 1,325 | - | - | Restricted Stock Units | |
| Novanta Inc | Mary Katherine Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2024 | 572 | 572 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mary Katherine Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 1,814 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mary Katherine Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 1,814 | 52,488 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mary Katherine Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 26,493 | 26,493 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mary Katherine Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mary Katherine Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 50,674 (0%) | 0% | 0 | Class A Common Stock | |
| Inogen Inc | Mary Katherine Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 21,871 | 46,273 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges